HB 943 Pennsylvania House · 2019-2020 Regular Session

An Act providing for consumer prescription drug pricing disclosure and pharmacy freedom to communicate.

Bill status signed all 5 stages cleared

Introduction

Apr 2019

Committee Review

Jul 2020

House Passage

Jul 2020

Senate Passage

Jun 2020

Signed into Law

Jul 2020

Introduced Apr 29, 2019 Signed Jul 23, 2020

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Jul 23, 2020

Signed into law

Approved by the Governor

lower

Jul 7, 2020

Lower · Passed

House concurred in Senate amendments

lower

Jul 7, 2020

Lower · Passed

Re-reported on concurrence, as committed

lower

Jul 7, 2020

Committee

Referred to RULES

lower

Jun 30, 2020

Upper · Passed

Third consideration and final passage

upper

Jun 29, 2020

Introduced

PN 4053 Amended on third consideration

upper

Jun 24, 2020

Upper · Passed

Re-reported as committed

upper

Apr 29, 2020

Committee

Re-referred to APPROPRIATIONS

upper

Apr 28, 2020

Upper · Passed

PN 3655 Reported as amended

upper

Nov 22, 2019

Committee

Referred to HEALTH AND HUMAN SERVICES

upper

Nov 20, 2019

Lower · Passed

Third consideration and final passage

lower

Nov 20, 2019

Lower · Passed

Re-reported as committed

lower

Nov 19, 2019

Committee

Re-committed to APPROPRIATIONS

lower

Sep 17, 2019

Lower · Passed

Re-reported as committed

lower

Jun 11, 2019

Committee

Re-committed to RULES

lower

Jun 11, 2019

Lower · Passed

PN 2089 Reported as amended

lower

Apr 29, 2019

Committee

PN 1587 Referred to HEALTH

lower

1 primary · 47 co-sponsors